remain bullish ci follow result mark strong core trend
meaning y/y/sequenti growth better expect
mcr rais guidanc addit commentari around upbeat
see addit tailwind synergi ramp strand cost
fuel beyond final ci continu gener robust
debt pay on-going capit deploy option
improv dramat beyond continu view valuat
risk/reward compel reiter buy pt ep
strong oper incom grow sequenti
margin expand bp retent rate sell
season strong result reflect expand custom base
ytd strong script volum sequenti
continu oper cost save tie suppli chain improv
esrx synergi addit specialti growth remain strong
differenti offer reson compani expect complet
integr legaci ci medic client end specialti
on-going front-burn area concern client expect accredo
evicor home healthcar profession continu reson
chronic diseas preval associ cost rise expect
compani on-going innov embarc benefit protect drive
outcom reduc cost improv patient satisfact lower gap care
compani specif qualiti score custom plan rate star
high patient satisfact np
expertis manag complex/chron patient popul view
medicar advantag busi pois attract growth
beyond compani expect membership growth least long-
term expect rang encourag earli
feedback ci clinic strength integr care capabl geographic/
product line expans would expect strong/ramp trend estim
assum growth growth would expect
on-going expans product line geograph remain tail wind
forese futur see opportun leverag compani
go deep market select recent texa
tr target
plu medicaid re-procur view rel immateri current serv
patient de minimi earn contributor impact expect continu view
medicaid attract potenti opportun medium/longer-term state increasingli look
manag highli complex patient popul area expertis
 enrol growth total membership strength select market
off-set weak nation account manag anticip strong trend
select core market continu compani fund agnost model
industri lead medic cost trend guidanc reson estim
assum continu attract growth select market repres account
better align vs nation account integr approach take full advantag
scope offer integr capabl specialti offer final compani integr
approach continu drive attract result medic cost remain well manag mcr
came ahead estim consensu
result best estim consensu adjust revenu came ahead
estim tie better premium pharmaci revenu stronger top-lin coupl
attract medic cost trend segment post impress sequenti
growth adjust oper incom vs solid sequenti perform
revenu growth margin expans bp sg ratio also came
lower expect tie on-going effici busi mix increas leverag adjust
ep solidli beat consensu compani also rais full
year guidanc adjust revenu prior midpoint adjust ep
 prior integr medic oper incom rais
midpoint rang mcr guidanc narrow
mid-point unchang manag also provid earli expect ep growth
 exclud prior period develop share repurchas activ growth
expect base exclud sever non-recur item absenc prior
year develop absenc tax benefit hif return
valuat risk/reward flow trend remain strong cffo handili beat
estim manag expect cash flow prior ci
continu improv financi flexibl pay debt lower debt-to-cap
would highlight expect signific uptick balanc sheet option
end compani reach target leverag ratio also bought back
share quarter anoth repurchas octob rais full year share
capac buyback deploy octob adjust
full year ep estim vs prior
reflect result updat guidanc ep continu view valuat
attract absolut rel basi think risk/reward compel reiter
buy rate price target
page
 group disabl premium
total revenu
revenu
revenu
compani document suntrust robinson humphrey estim exclud one-tim charg transit client adjust add back
revenu reflect transit client exclud
page
provid health servic global four divis integr medic
group disabl integr medic offer medic solut across broad
rang market commerci govern integr offer local focu
segment provid pharmaci medic manag servic includ major
legaci express script busi group disabl cover group disabl life
product intern divis cover varieti product servic intern
market employe multi-n compani
reiter buy rate ci see signific on-going opportun across busi would
expect compani highli integr value-bas approach continu reson market
look on-going share gain addit think strategic/financi benefit esrx deal
underappreci view valuat risk/reward compel
valuat risk
trade ep meaning discount manag care group averag tie
larg view discount industri concern appreci valu
acquisit esrx like compani integr offer attract absolute/rel medic
trend strong cash flow clinic capabl price target base ci trade
ep premium current multipl view appropri given attract growth
opportun across broad rang area risk includ exposur commerci market
view less attract growth prospect vs govern pay meaning membership
attrit recent sizabl esrx acquisit bring integr risk
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
